Mr. Kendall assumed the role of Chief Executive Officer at MonoSol Rx in 2014 after serving as Co-president and Chief Operating Officer for the Company since 2011. Mr. Kendall also served as Executive Vice President and Chief Financial Officer of MonoSol Rx since July 2006. From February 1999 to June 2006, he was the Vice President and Managing Director of the Americas for Hewlett Packard Financial Services. Mr. Kendall held a number of positions with AT&T Capital Corporation including President of AT&T Credit Corporation and NCR Credit Corporation from 1985 to 1998.
Mr. Schobel was appointed as Chief Innovation & Technology Officer of MonoSol Rx in 2014 after serving as the Company's Chief Executive Officer, Co-President and a member of its Board of Directors since November 2005. From March 2001 to November 2005, he was the Global Head of New Technology and Product Innovation for the Consumer Health Business Unit at Novartis where he pioneered thin film delivery of systemic drugs. Prior to Novartis, Mr. Schobel held various general management positions with Reed & Carnrick Pharmaceuticals, Warner-Lambert, and Pharmaceutical Formulations Inc.
Mr. Barber joined MonoSol Rx in July 2007. Prior to joining MonoSol Rx, Mr. Barber held managerial positions with Quest Diagnostics and Xerox Corporation. While at Quest Diagnostics, Mr. Barber held positions in their corporate planning and international divisions. During his time at Xerox Corporation, Mr. Barber held several finance roles in their North America division. Mr. Barber received his BA degree from SUNY Geneseo and an MBA from Seton Hall University.
Mr. Boyd joined the MonoSol Rx team in August of 2013 to oversee project delivery. Prior to joining the Company, Mr. Boyd served as Senior Director of Operations for the Americas and APJ Regions, at Hewlett-Packard Company. Throughout his 15-year career at Hewlett-Packard Company, Mr. Boyd held a variety of positons in business process improvement and in operations. Mr. Boyd earned a BA in History from Wittenberg University and a MBA in Finance from Seton Hall University. Mr. Boyd also earned a Master's of Science in Management and Urban Policy Analysis from the New School University in New York, NY.
Ms. Wood has led the Human Resources function since October 2006. Prior to joining MonoSol Rx, Ms. Wood was the Director, Human Resources for Hewlett Packard Financial Services’ Americas division from 1999 to 2006. From 1995 to 1998, Ms. Wood provided consulting services to several companies in the Financial Services, Healthcare and Consumer Goods market. Prior to that, Ms. Wood spent seven years with Sea-Land Service Corp.
Mr. DiPalma brings over 30 years of experience as a CFO, COO, and CEO in emerging life sciences companies, both public and private. He is Managing Director of Danforth Advisors LLC, a Boston-based strategic and financial consultancy. Previously, Mr. DiPalma was CFO of FORUM Pharmaceuticals from 2009 to 2014, and CFO of RXi Pharmaceuticals from 2007 to 2009, and was founder and CEO of Catalyst Oncology from 2004 to 2007. Mr. DiPalma was Chairman of the Board of Cognoptix, and is on the Board of Directors of Phytera, Inc. Mr. DiPalma holds a BS from the University of Massachusetts and an MBA from Babson College.